Management of hyperleukocytosis in pediatric acute myeloid leukemia using immediate chemotherapy without leukapheresis: results from the NOPHO-DBH AML 2012 protocol.

Autor: Zeller B; Department of Pediatric Hematology-Oncology, Oslo University Hospital, Oslo. bzeller@ous-hf.no., Arad-Cohen N; Department of Pediatric Hemato-Oncology, Rambam Health Care Campus, Haifa., Cheuk D; Department of Pediatrics and Adolescent Medicine, Hong Kong Children's Hospital and Hong Kong Pediatric Hematology and Oncology Study Group (HKPHOSG), Hong Kong., De Moerloose B; Department of Pediatric Hematology-Oncology, Ghent University Hospital, Gent., Navarro JMF; Department of Pediatric Hemato-Oncology, Hospital Universitario y Politecnico La Fe, Valencia., Hasle H; Department of Pediatrics and Adolescent Medicine, Aarhus University Hospital, Aarhus., Jahnukainen K; New Children's hospital, Pediatric Research Center, University of Helsinki and Helsinki University Hospital, Helsinki, Finland., Juul-Dam KL; Department of Pediatrics and Adolescent Medicine, Aarhus University Hospital, Aarhus., Kaspers G; Princess Maxima Center for Pediatric Oncology, Utrecht, and Emma Children's Hospital, Amsterdam UMC, Vrije Universiteit Amsterdam., Kovalova Z; Department of Pediatric Oncology/Hematology, Children's Clinical University Hospital, Riga, Latvia., Jonsson OG; Department of Pediatrics, Landspitali University Hospital, Reykjavik, Iceland., Lausen B; Department of Pediatrics and Adolescent Medicine, Rigshospitalet, University of Copenhagen., Munthe-Kaas M; Department of Pediatric Hematology-Oncology, Oslo University Hospital, Oslo., Nystrom UN; Department of Clinical Sciences, Pediatrics, Umea University, Umea., Palle J; Department of Women's and Children's Health, Uppsala University, Uppsala., Pasauliene R; Center of Oncology and Hematology, BMT Unit, Vilnius University Children's Hospital, Vilnius, Lithuania., Pronk CJ; Childhood Cancer Center, Skane University Hospital, Lund., Saks K; Department of Pediatrics, SA Tallinna Lastehaigla, Tallinn, Estonia., Tierens A; Laboratory Medicine Program, Hematopathology, University Health Network, Toronto, ON, Canada., Abrahamsson J; Institution for Clinical Sciences, Department of Pediatrics, Sahlgrenska Academy, University of Gothenburg, Gothenburg.

Publikováno v: Haematologica [Haematologica] 2024 Sep 01; Vol. 109 (9), pp. 2873-2883. Date of Electronic Publication: 2024 Sep 01.

Stem cell collection and hematological recovery in the Fondazione Italiana Linfomi (FIL) MCL0208 clinical trial.

Autor: Clerico M; Division of Hematology, AOU 'Città della Salute e della Scienza di Torino', Torino, Italy., Ferrero S; Division of Hematology, AOU 'Città della Salute e della Scienza di Torino', Torino, Italy. simone.ferrero@unito.it.; Department of Molecular Biotechnologies and Health Sciences, University of Torino, Torino, Italy. simone.ferrero@unito.it., Alessandria B; Department of Molecular Biotechnologies and Health Sciences, University of Torino, Torino, Italy., Zaccaria GM; Department of Electrical and Information Engineering (DEI), Polytechnic University of Bari, Bari, Italy., Genuardi E; Department of Molecular Biotechnologies and Health Sciences, University of Torino, Torino, Italy., Ragaini S; Division of Hematology, AOU 'Città della Salute e della Scienza di Torino', Torino, Italy.; Department of Molecular Biotechnologies and Health Sciences, University of Torino, Torino, Italy., Tavarozzi R; SC Ematologia Azienda Ospedaliera Santi Antonio e Biagio e Cesare Arrigo, Alessandria, Italy.; Division of Hematology, Department of Translational Medicine, University of Eastern Piedmont, Novara, Italy., Cavallo F; Division of Hematology, AOU 'Città della Salute e della Scienza di Torino', Torino, Italy.; Department of Molecular Biotechnologies and Health Sciences, University of Torino, Torino, Italy., Hohaus S; Institute of Hematology, Università Cattolica del Sacro Cuore and Fondazione Policlinico Univeristario A. Gemelli, Roma, Italy., Musuraca G; IRCCS, IRST Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori 'Dino Amadori', Meldola, Italy., Carella AM; Department of Hematology and Bone Marrow Transplant, IRCSS Casa Sollievo Della Sofferenza, San Giovanni Rotondo, Italy., Stelitano C; Department of Hematology, Azienda Ospedaliera Bianchi Melacrino Morelli, Reggio Calabria, Italy., Tani M; UOC di Ematologia, Ospedale S. Maria delle Croci, Ravenna, Italy., Gaidano G; Division of Hematology, Department of Translational Medicine, University of Eastern Piedmont, Novara, Italy., Olivieri J; Clinica Ematologica, Azienda Sanitaria Universitaria Integrata di Udine, Udine, Italy., Usai SV; Ematologia e CTMO, Ospedale Businco, Cagliari, Italy., Galimberti S; Division of Hematology, University Hospital of Pisa, Pisa, Italy., Re F; Division of Immuno-Haematology, AOU Parma, Parma, Italy., Mian M; Innovation, Research and Teaching Service (SABES-ASDAA), Teaching Hospital of the Paracelsus Medical Private University (PMU), Bolzano, Italy.; College of Health Care-Professions Claudiana, Bozen, Italy., Castellino C; Division of Hematology, Azienda Ospedaliera S. Croce e Carle, Cuneo, Italy., Pavone V; Ospedale Pia Fondazione Cardinale Panico, Tricase, Lecce, Italy., Evangelista A; Unit of Clinical Epidemiology, AOU 'Città della Salute e della Scienza di Torino' and CPO Piemonte, Torino, Italy., Bruno B; Division of Hematology, AOU 'Città della Salute e della Scienza di Torino', Torino, Italy.; Department of Molecular Biotechnologies and Health Sciences, University of Torino, Torino, Italy., Cortelazzo S; Oncology Unit, Humanitas/Gavazzeni Clinic, Bergamo, Italy., Passera R; Department of Medical Sciences, University of Torino, Torino, Italy., Ladetto M; SC Ematologia Azienda Ospedaliera Santi Antonio e Biagio e Cesare Arrigo, Alessandria, Italy.; Division of Hematology, Department of Translational Medicine, University of Eastern Piedmont, Novara, Italy.

Publikováno v: Scientific reports [Sci Rep] 2024 Jul 23; Vol. 14 (1), pp. 16946. Date of Electronic Publication: 2024 Jul 23.

Combined peripheral blood monocyte count and white blood cell count as a guide for successful one-day autologous peripheral blood stem cell collection.

Autor: Watanaboonyongcharoen P; Department of Laboratory Medicine, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand.; Transfusion Medicine Unit, King Chulalongkorn Memorial Hospital, Bangkok, Thailand.; Renal Immunology and Renal Transplant Research Unit, Chulalongkorn University, Bangkok, Thailand.; Center of Excellence in Translational Hematology, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand., Lorucharoen N; Transfusion Medicine Unit, King Chulalongkorn Memorial Hospital, Bangkok, Thailand., Wudhikarn K; Center of Excellence in Translational Hematology, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand.; Department of Medicine, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand., Bunworasate U; Center of Excellence in Translational Hematology, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand.; Department of Medicine, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand., Chanswangphuwana C; Center of Excellence in Translational Hematology, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand.; Department of Medicine, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand., Rojnuckarin P; Transfusion Medicine Unit, King Chulalongkorn Memorial Hospital, Bangkok, Thailand.; Center of Excellence in Translational Hematology, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand.; Department of Medicine, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand.

Publikováno v: International journal of laboratory hematology [Int J Lab Hematol] 2024 Dec; Vol. 46 (6), pp. 1029-1035. Date of Electronic Publication: 2024 Jul 29.

Diagnostic leukapheresis reveals distinct phenotypes of NSCLC circulating tumor cells.

Autor: Rieckmann LM; Department of Personalized Oncology, DKFZ-Hector Cancer Institute, University Medical Center Mannheim, Medical Faculty Mannheim, University of Heidelberg, Mannheim, Germany.; Division of Personalized Medical Oncology (A420), German Cancer Research Center (DKFZ), Heidelberg, Germany.; German Center for Lung Research (DZL), Heidelberg, Germany.; Department of Personalized Oncology, University Hospital Mannheim, Medical Faculty Mannheim, University of Heidelberg, Mannheim, Germany., Spohn M; Bioinformatics Core, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.; Clinic of Pediatric Hematology and Oncology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.; Research Institute Children's Cancer Center Hamburg, Hamburg, Germany.; Department of Oncology, Hematology and Bone Marrow Transplantation With Section Pneumology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany., Ruff L; Department of Personalized Oncology, DKFZ-Hector Cancer Institute, University Medical Center Mannheim, Medical Faculty Mannheim, University of Heidelberg, Mannheim, Germany.; Division of Personalized Medical Oncology (A420), German Cancer Research Center (DKFZ), Heidelberg, Germany.; German Center for Lung Research (DZL), Heidelberg, Germany.; Department of Personalized Oncology, University Hospital Mannheim, Medical Faculty Mannheim, University of Heidelberg, Mannheim, Germany., Agorku D; Miltenyi Biotec B.V. & Co. KG, R&D, Bergisch Gladbach, Germany., Becker L; Heidelberg Institute for Stem Cell Technology and Experimental Medicine (HI-STEM GmbH), Heidelberg, Germany.; Division of Stem Cells and Cancer, German Cancer Research Center, (DKFZ-ZMBH Alliance), Heidelberg, Germany., Borchers A; III. Department of Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.; Hamburg Center for Translational Immunology (HCTI), University Medical Center Hamburg-Eppendorf, Hamburg, Germany., Krause J; I. Department of Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany., O'Reilly R; Department of Personalized Oncology, DKFZ-Hector Cancer Institute, University Medical Center Mannheim, Medical Faculty Mannheim, University of Heidelberg, Mannheim, Germany.; Division of Personalized Medical Oncology (A420), German Cancer Research Center (DKFZ), Heidelberg, Germany.; German Center for Lung Research (DZL), Heidelberg, Germany.; Department of Personalized Oncology, University Hospital Mannheim, Medical Faculty Mannheim, University of Heidelberg, Mannheim, Germany., Hille J; Department of Oncology, Hematology and Bone Marrow Transplantation With Section Pneumology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.; Department of Tumor Biology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany., Velthaus-Rusik JL; Department of Oncology, Hematology and Bone Marrow Transplantation With Section Pneumology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany., Beumer N; Department of Personalized Oncology, DKFZ-Hector Cancer Institute, University Medical Center Mannheim, Medical Faculty Mannheim, University of Heidelberg, Mannheim, Germany.; Division of Personalized Medical Oncology (A420), German Cancer Research Center (DKFZ), Heidelberg, Germany.; German Center for Lung Research (DZL), Heidelberg, Germany.; Division of Applied Bioinformatics, German Cancer Research Center (DKFZ), Heidelberg, Germany.; Faculty of Biosciences, Heidelberg University, Heidelberg, Germany., Günther A; Department of Personalized Oncology, DKFZ-Hector Cancer Institute, University Medical Center Mannheim, Medical Faculty Mannheim, University of Heidelberg, Mannheim, Germany.; Division of Personalized Medical Oncology (A420), German Cancer Research Center (DKFZ), Heidelberg, Germany.; German Center for Lung Research (DZL), Heidelberg, Germany.; Department of Personalized Oncology, University Hospital Mannheim, Medical Faculty Mannheim, University of Heidelberg, Mannheim, Germany.; Faculty of Biosciences, Heidelberg University, Heidelberg, Germany., Willnow L; Department of Personalized Oncology, DKFZ-Hector Cancer Institute, University Medical Center Mannheim, Medical Faculty Mannheim, University of Heidelberg, Mannheim, Germany.; Division of Personalized Medical Oncology (A420), German Cancer Research Center (DKFZ), Heidelberg, Germany.; German Center for Lung Research (DZL), Heidelberg, Germany.; Department of Personalized Oncology, University Hospital Mannheim, Medical Faculty Mannheim, University of Heidelberg, Mannheim, Germany., Imbusch CD; Division of Applied Bioinformatics, German Cancer Research Center (DKFZ), Heidelberg, Germany., Iglauer P; Institute of Pathology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany., Simon R; Institute of Pathology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany., Franzenburg S; Institute of Clinical Molecular Biology, Christian-Albrechts-University and University Hospital Schleswig-Holstein, Kiel, Germany., Winter H; Translational Lung Research Center Heidelberg, Member of the German Center for Lung Research (DZL), Department of Thoracic Oncology, Thoraxklinik at University Hospital Heidelberg, Heidelberg, Germany., Thomas M; Translational Lung Research Center Heidelberg, Member of the German Center for Lung Research (DZL), Department of Thoracic Oncology, Thoraxklinik at University Hospital Heidelberg, Heidelberg, Germany., Bokemeyer C; Department of Oncology, Hematology and Bone Marrow Transplantation With Section Pneumology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany., Gagliani N; Hamburg Center for Translational Immunology (HCTI), University Medical Center Hamburg-Eppendorf, Hamburg, Germany.; I. Department of Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.; Department of General, Visceral and Thoracic Surgery, University Medical Center Hamburg-Eppendorf, Hamburg, Germany., Krebs CF; III. Department of Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.; Hamburg Center for Translational Immunology (HCTI), University Medical Center Hamburg-Eppendorf, Hamburg, Germany., Sprick M; Heidelberg Institute for Stem Cell Technology and Experimental Medicine (HI-STEM GmbH), Heidelberg, Germany.; Division of Stem Cells and Cancer, German Cancer Research Center, (DKFZ-ZMBH Alliance), Heidelberg, Germany., Hardt O; Miltenyi Biotec B.V. & Co. KG, R&D, Bergisch Gladbach, Germany., Riethdorf S; Department of Tumor Biology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany., Trumpp A; Heidelberg Institute for Stem Cell Technology and Experimental Medicine (HI-STEM GmbH), Heidelberg, Germany.; Division of Stem Cells and Cancer, German Cancer Research Center, (DKFZ-ZMBH Alliance), Heidelberg, Germany., Stoecklein NH; General, Visceral and Pediatric Surgery, University Hospital and Medical Faculty, Heinrich-Heine-University Düsseldorf, Düsseldorf, Germany., Peine S; Institute of Transfusion Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany., Rosenstiel P; Institute of Clinical Molecular Biology, Christian-Albrechts-University and University Hospital Schleswig-Holstein, Kiel, Germany., Pantel K; Department of Tumor Biology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany., Loges S; Department of Personalized Oncology, DKFZ-Hector Cancer Institute, University Medical Center Mannheim, Medical Faculty Mannheim, University of Heidelberg, Mannheim, Germany.; Division of Personalized Medical Oncology (A420), German Cancer Research Center (DKFZ), Heidelberg, Germany.; German Center for Lung Research (DZL), Heidelberg, Germany.; Department of Personalized Oncology, University Hospital Mannheim, Medical Faculty Mannheim, University of Heidelberg, Mannheim, Germany.; Department of Oncology, Hematology and Bone Marrow Transplantation With Section Pneumology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.; Department of Tumor Biology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany., Janning M; Department of Personalized Oncology, DKFZ-Hector Cancer Institute, University Medical Center Mannheim, Medical Faculty Mannheim, University of Heidelberg, Mannheim, Germany. melanie.janning@dkfz-heidelberg.de.; Division of Personalized Medical Oncology (A420), German Cancer Research Center (DKFZ), Heidelberg, Germany. melanie.janning@dkfz-heidelberg.de.; German Center for Lung Research (DZL), Heidelberg, Germany. melanie.janning@dkfz-heidelberg.de.; Department of Personalized Oncology, University Hospital Mannheim, Medical Faculty Mannheim, University of Heidelberg, Mannheim, Germany. melanie.janning@dkfz-heidelberg.de.; Department of Oncology, Hematology and Bone Marrow Transplantation With Section Pneumology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany. melanie.janning@dkfz-heidelberg.de.; Department of Tumor Biology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany. melanie.janning@dkfz-heidelberg.de.

Publikováno v: Molecular cancer [Mol Cancer] 2024 May 08; Vol. 23 (1), pp. 93. Date of Electronic Publication: 2024 May 08.

A critical time window for leukapheresis product transportation to manufacture clinical-grade dendritic cells with optimal anti-tumor activities.

Autor: Wang W; Departments of Obstetrics & Gynecology and Pediatrics, West China Second University Hospital, Key Laboratory of Birth Defects and Related Diseases of Women and Children, Ministry of Education, Development and Related Diseases of Women and Children Key Laboratory of Sichuan Province, Center of Growth, Metabolism and Aging, State Key Laboratory of Biotherapy and Collaborative Innovation Center of Biotherapy, Sichuan University, Chengdu, Sichuan, China; Xinxiang Central Hospital, The Fourth Clinical College of Xinxiang Medical University, Xinxiang, Henan, China., Jiang J; Non-coding RNA and Drug Discovery Key Laboratory of Sichuan Province, Chengdu Medical College, Chengdu, Sichuan, China., Yang C; Departments of Obstetrics & Gynecology and Pediatrics, West China Second University Hospital, Key Laboratory of Birth Defects and Related Diseases of Women and Children, Ministry of Education, Development and Related Diseases of Women and Children Key Laboratory of Sichuan Province, Center of Growth, Metabolism and Aging, State Key Laboratory of Biotherapy and Collaborative Innovation Center of Biotherapy, Sichuan University, Chengdu, Sichuan, China., Meng X; Division of Cell Manufacturing, Sichuan Cunde Therapeutics, Chengdu, Sichuan, China., Gao L; Division of Cell Manufacturing, Sichuan Cunde Therapeutics, Chengdu, Sichuan, China., Yuan Y; Division of Cell Manufacturing, Sichuan Cunde Therapeutics, Chengdu, Sichuan, China., Lei T; Division of Cell Manufacturing, Sichuan Cunde Therapeutics, Chengdu, Sichuan, China., Ding P; Non-coding RNA and Drug Discovery Key Laboratory of Sichuan Province, Chengdu Medical College, Chengdu, Sichuan, China. Electronic address: dingping@cmc.edu.cn., Yin R; Departments of Obstetrics & Gynecology and Pediatrics, West China Second University Hospital, Key Laboratory of Birth Defects and Related Diseases of Women and Children, Ministry of Education, Development and Related Diseases of Women and Children Key Laboratory of Sichuan Province, Center of Growth, Metabolism and Aging, State Key Laboratory of Biotherapy and Collaborative Innovation Center of Biotherapy, Sichuan University, Chengdu, Sichuan, China. Electronic address: yinrutie@scu.edu.cn., Li Q; Departments of Obstetrics & Gynecology and Pediatrics, West China Second University Hospital, Key Laboratory of Birth Defects and Related Diseases of Women and Children, Ministry of Education, Development and Related Diseases of Women and Children Key Laboratory of Sichuan Province, Center of Growth, Metabolism and Aging, State Key Laboratory of Biotherapy and Collaborative Innovation Center of Biotherapy, Sichuan University, Chengdu, Sichuan, China. Electronic address: liqintong@scu.edu.cn.

Publikováno v: Cytotherapy [Cytotherapy] 2024 Feb; Vol. 26 (2), pp. 210-220. Date of Electronic Publication: 2023 Dec 19.